樂心醫療(300562.SZ)一季度淨利預增90%-120%
格隆匯3月1日丨樂心醫療(300562.SZ)披露2020年第一季度業績預告,期內,預計歸屬於上市公司股東的淨利潤468.64萬元–542.64萬元,同比增長90%-120%。
業績變動原因説明:
1、報告期內,公司致力於針對運動健康、慢病管理等領域為廣大客户提供健康IoT與大數據整體解決方案戰略,行業繼續保持良好的增長態勢。公司積極拓展國內外高端市場,持續加大創新研發投入,不斷提升核心競爭力,大客户戰略成效顯着,同時加強內部管理,提升投入產出效益,公司業績實現較快增長。
2020年第一季度,公司高度關注新型冠狀病毒疫情發展,積極應對,第一時間成立疫情防控小組,做好自身相關防控工作,通過遠程協同辦公等多種方式做好客户運營維護,同時不斷強化內外部管理,靈活調整員工返崗時間,保障安全有序復工,確保公司生產經營管理事項正常開展。
2、報告期內,公司非經常性損益對淨利潤的影響額預計為55萬元左右。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.